网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
类风湿性关节炎与乳腺癌因果关联:两样本孟德尔随机化研究和荟萃分析
作者:赵娜  刘治璞  王洪星  张义 
单位:山东大学齐鲁医院 检验科, 山东 济南 250012
关键词:类风湿性关节炎 乳腺癌 孟德尔随机化 因果关系 荟萃分析 
分类号:R593.22;R737.9
出版年·卷·期(页码):2024·52·第十二期(1838-1843)
摘要:

目的 :利用两样本孟德尔随机化(TSMR)和荟萃分析的方法探讨类风湿性关节炎(RA)与乳腺癌的因果关系。方法 :采用逆方差加权(IVW)、加权中位数、Egger回归、简单模式和加权模式方法,对在线可访问数据集进行TSMR分析,利用EBI数据库进行荟萃分析。结果 :正向TSMR (OR=0.947,95%CI 0.914~0.982,P=0.003)和EBI数据库荟萃分析(OR=0.97,95%CI 0.96~0.99)表明,RA与乳腺癌患病风险具有因果关系。采用留一法剔除SNP后,TSMR分析结果稳健。反向TSMR结果表明,乳腺癌与RA不具有因果关系(OR=0.976,95%CI 0.936~1.019,P=0.268)。结论 :RA与乳腺癌之间存在负相关因果关系,这为揭示RA与癌症患病风险的关系提供参考。

Objective:To explore the causal relationship between rheumatoid arthritis(RA) and breast cancer by two-sample Mendelian randomization(TSMR) and Meta-analysis.Methods:Inverse variance weighting(IVW), weighted median, Egger regression, simple mode and weighted mode methods were used to perform TSMR analysis on online accessible data sets, and Meta-analysis was conducted using the EBI database.Results:Positive TSMR(OR=0.947, 95%CI 0.914-0.982, P=0.003) and EBI database Meta-analysis(OR=0.97, 95%CI 0.96-0.99), indicating that RA had a causal relationship with the risk of breast cancer. After using the leave-one-out method to eliminate SNPs, the TSMR analysis results were robust. The reverse TSMR results showed that there was no causal relationship between breast cancer and RA(OR=0.976, 95%CI 0.936-1.019, P=0.268).Conclusion: There is a negative causal relationship between RA and breast cancer, which provides a reference for revealing the relationship between RA and the risk of cancer.

参考文献:

[1] GEBRESELASSIE A,ADULI F,HOWELL C D.Rheumatologic diseases and the liver[J].Clin Liver Dis,2019,23:247-261.
[2] FIGUS F A,PIGA M,AZZOLIN I,et al.Rheumatoid arthritis:extra-articular manifestations and comorbidities[J].Autoimmun Rev,2021,20:102776.
[3] AKIYAMA M,KANEKO Y.Pathogenesis,clinical features,and treatment strategy for rheumatoid arthritis-associated interstitial lung disease[J].Autoimmun Rev,2022,21:103056.
[4] SPARKS J A.Rheumatoid arthritis[J].Ann Intern Med,2019,170:ITC1-ITC16.
[5] RAASCHOU P,SIMARD J F,ASKER HAGELBERG C,et al.Rheumatoid arthritis,anti-tumour necrosis factor treatment,and risk of squamous cell and basal cell skin cancer:cohort study based on nationwide prospectively recorded data from Sweden[J].BMJ,2016,28; 352:i262.
[6] 俞柏竹,陈军磊,张振国,等.两样本孟德尔随机化分析研究肠道微生物与阿尔兹海默症之间的关系[J].现代医学,2023,51(11):1532-1539.
[7] BURGESS S,SCOTT R A,TIMPSON N J,et al.Using published data in Mendelian randomization:a blueprint for efficient identification of causal risk factors[J].Eur J Epidemiol,2015,30:543-552.
[8] 唐伟,徐向楠,符德元.精神分裂症与乳腺癌之间关联的孟德尔随机化研究[J].现代医学,2024,52(1):96-101.
[9] SHIM H,CHASMAN D I,SMITH J D,et al.A multivariate genome-wide association analysis of 10 LDL subfractions,and their response to statin treatment,in 1868 Caucasians[J].PLoS One,2015,10:e0120758.
[10] 孙继宏,丛静,王萍玉.lncRNAs与肺腺癌因果关联的两样本孟德尔随机化研究[J].中华疾病控制杂志,2023,27(11):1350-1353,1359.
[11] LEE Y K,BAE S C.Mortality in Korean patients with rheumatoid arthritis[J].J Rheum Dis,2021,28:113-118.
[12] BEYAERT R,BEAUGERIE L,VAN ASSCHE G,et al.Cancer risk in immune-mediated inflammatory diseases(IMID)[J].Mol Cancer,2013,12:1-12.
[13] SIMON T A,THOMPSON A,GANDHI K K,et al.Incidence of malignancy in adult patients with rheumatoid arthritis:a Meta-analysis[J].Arthritis Res Ther,2015,17:212.
[14] CHO M H,CHO J H,EUN Y,et al.Rheumatoid arthritis and risk of lung cancer:a nationwide cohort study[J].J Thorac Oncol,2024,19(2):216-226.
[15] LUO X,HE Y,XU W,et al.The risk of leukemia in patients with rheumatoid arthritis:a systematic review and Meta-analysis[J].Clin Rheumatol,2021,40(4):1283-1289.
[16] KIM S C,GLYNN R J,GIOVANNUCCI E,et al.Risk of high-grade cervical dysplasia and cervical cancer in women with systemic infammatory diseases:a population-based cohort study[J].Ann Rheum Dis,2015,74(7):1360-1367.
[17] YANG T O,FLOUD S,REEVES G K,et al.Rheumatoid arthritis and cancer risk in the million women study[J].Int J Epidemiol,2024,14,53(2):dyae006.
[18] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71:209-249.
[19] TIAN G,LIANG J N,WANG Z Y,et al.Breast cancer risk in rheumatoid arthritis:an update Meta-analysis[J].Biomed Res Int,2014,2014:453012.
[20] AHN C,LEE S,PARK S K.Causal Inference between rheumatoid arthritis and breast cancer in east asian and european population:a two-sample Mendelian randomization[J].Cancers(Basel),2020,12(11):3272.
[21] YUAN S,CHEN J,RUAN X,et al.Rheumatoid arthritis and risk of site-specific cancers:Mendelian randomization study in European and East Asian populations[J].Arthritis Res Ther,2022,24(1):270.
[22] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68:394-424.
[23] PETERSON R E,KUCHENBAECKER K,WALTERS R K,et al.Genome-wide association studies in ancestrally diverse populations:opportunities,methods,pitfalls,and recommendations[J].Cell,2019,179(3):589-603.
[24] FAN J,JIANG T,HE D.Genetic link between rheumatoid arthritis and autoimmune liver diseases:a two-sample Mendelian randomization study[J].Semin Arthritis Rheum,2023,58:152142.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 853805 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

本系统由北京博渊星辰网络科技有限公司设计开发 技术支持电话:010-63361626

苏ICP备09058541